Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3)

Overview of attention for article published in Orphanet Journal of Rare Diseases, May 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Eliglustat

Cited by Canadian Agency for Drugs and Technologies in Health on 09 Aug 2017

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Eliglustat

Cited by Canadian Agency for Drugs and Technologies in Health on 04 Aug 2017

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.